In Vivo Confocal Microscopy in Different Types of Dry Eye and Meibomian Gland Dysfunction
Abstract
:1. Introduction
2. Materials and Methods
2.1. Study Objective and Definition of Reference Standard
2.2. Literature Search Strategy
2.3. Eligibility Criteria
2.4. Data Extraction and Quality Evaluation of the Studies
3. Results
3.1. Meibomian Gland Dysfunction
3.2. Dry Eye Disease
3.3. Sjogren’s-Related Dry Eye (SSDE)
3.4. The Use of IVCM to Evaluate the Treatment for Dry Eye
3.5. Systemic Disease
3.6. Glaucoma Treatment-Related Dry Eyes
3.7. Corneal Graft Versus Host Disease (GVHD)
3.8. Contact Lens-Related Conditions
4. Discussion
4.1. Limitations
4.2. Future Research Directions
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Cruzat, A.; Pavan-Langston, D.; Hamrah, P. In Vivo Confocal Microscopy of Corneal Nerves: Analysis and Clinical Correlation. Semin. Ophthalmol. 2010, 25, 171–177. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Dua, H.S.; Faraj, L.; Said, D.G.; Gray, T.; Lowe, J. Human Corneal Anatomy Redefined. Ophthalmology 2013, 120, 1778–1785. [Google Scholar] [CrossRef] [PubMed]
- Bohn, S.; Sperlich, K.; Stahnke, T.; Schünemann, M.; Stolz, H.; Guthoff, R.F.; Stachs, O. Multiwavelength confocal laser scanning microscopy of the cornea. Biomed. Opt. Express 2020, 11, 5689–5700. [Google Scholar] [CrossRef] [PubMed]
- Stachs, O.; Guthoff, R.F.; Aumann, S. In Vivo Confocal Scanning Laser Microscopy. In High Resolution Imaging in Microscopy and Ophthalmology; Springer: Berlin/Heidelberg, Germany, 2019; pp. 263–284. [Google Scholar] [CrossRef] [Green Version]
- Khamar, P.; Nair, A.P.; Shetty, R.; Vaidya, T.; Subramani, M.; Ponnalagu, M.; Dhamodaran, K.; D’Souza, S.; Ghosh, A.; Pahuja, N.; et al. Dysregulated Tear Fluid Nociception-Associated Factors, Corneal Dendritic Cell Density, and Vitamin D Levels in Evaporative Dry Eye. Investig. Opthalmol. Vis. Sci. 2019, 60, 2532–2542. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Cruzat, A.; Qazi, Y.; Hamrah, P. In Vivo Confocal Microscopy of Corneal Nerves in Health and Disease. Ocul. Surf. 2016, 15, 15–47. [Google Scholar] [CrossRef] [Green Version]
- Schmidl, D.; Schlatter, A.; Chua, J.; Tan, B.; Garhöfer, G.; Schmetterer, L. Novel Approaches for Imaging-Based Diagnosis of Ocular Surface Disease. Diagnostics 2020, 10, 589. [Google Scholar] [CrossRef]
- Binotti, W.W.; Bayraktutar, B.; Ozmen, M.C.; Cox, S.M.; Hamrah, P. A Review of Imaging Biomarkers of the Ocular Surface. Eye Contact Lens Sci. Clin. Pract. 2020, 46, S84–S105. [Google Scholar] [CrossRef]
- Shea, B.J.; Reeves, B.C.; Wells, G.; Thuku, M.; Hamel, C.; Moran, J.; Moher, D.; Tugwell, P.; Welch, V.; Kristjansson, E.; et al. AMSTAR 2: A critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ 2017, 358, j4008. [Google Scholar] [CrossRef] [Green Version]
- Sterne, J.A.C.; Savović, J.; Page, M.J.; Elbers, R.G.; Blencowe, N.S.; Boutron, I.; Cates, C.J.; Cheng, H.Y.; Corbett, M.S.; Eldridge, S.M.; et al. RoB 2: A revised tool for assessing risk of bias in randomised trials. BMJ 2019, 366, l4898. [Google Scholar] [CrossRef] [Green Version]
- Efron, N.; Al-Dossari, M.; Pritchard, N. In Vivo Confocal Microscopy of the Palpebral Conjunctiva and Tarsal Plate. Optom. Vis. Sci. 2009, 86, E1303–E1308. [Google Scholar] [CrossRef]
- Chhadva, P.; Goldhardt, R.; Galor, A. Meibomian Gland Disease: The Role of Gland Dysfunction in Dry Eye Disease. Ophthalmology 2017, 124, S20–S26. [Google Scholar] [CrossRef] [PubMed]
- Zhao, H.; Chen, J.-Y.; Wang, Y.-Q.; Lin, Z.-R.; Wang, S. In vivo Confocal Microscopy Evaluation of Meibomian Gland Dysfunction in Dry Eye Patients with Different Symptoms. Chin. Med. J. 2016, 129, 2617–2622. [Google Scholar] [CrossRef] [PubMed]
- Qazi, Y.; Kheirkhah, A.; Blackie, C.; Cruzat, A.; Trinidad, M.; Williams, C.; Korb, D.R.; Hamrah, P. In vivo detection of clinically non-apparent ocular surface inflammation in patients with meibomian gland dysfunction-associated refractory dry eye symptoms: A pilot study. Eye 2015, 29, 1099–1110. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Qazi, Y.; Kheirkhah, A.; Blackie, C.; Trinidad, M.; Williams, C.; Cruzat, A.; Korb, D.R.; Hamrah, P. Clinically Relevant Immune-Cellular Metrics of Inflammation in Meibomian Gland Dysfunction. Investig. Opthalmol. Vis. Sci. 2018, 59, 6111–6123. [Google Scholar] [CrossRef]
- Craig, J.P.; Nichols, K.K.; Akpek, E.K.; Caffery, B.; Dua, H.S.; Joo, C.-K.; Liu, Z.; Nelson, J.D.; Nichols, J.J.; Tsubota, K.; et al. TFOS DEWS II Definition and Classification Report. Ocul. Surf. 2017, 15, 276–283. [Google Scholar] [CrossRef]
- Azizi, S.; Uçak, T.; Yaşar, I.; Karakurt, Y.; Erdogan, E.; Salman, I. Evaluation of the Corneal Layers in Meibomian-Gland-Dysfunction-Related Dry Eye by In Vivo Slit-Scanning Confocal Microscopy. Semin. Ophthalmol. 2017, 32, 377–383. [Google Scholar] [CrossRef]
- Stern, M.E.; Schaumburg, C.S.; Pflugfelder, S.C. Dry Eye as a Mucosal Autoimmune Disease. Int. Rev. Immunol. 2013, 32, 19–41. [Google Scholar] [CrossRef]
- Al-Aqaba, M.A.; Dhillon, V.K.; Mohammed, I.; Said, D.G.; Dua, H.S. Corneal nerves in health and disease. Prog. Retin. Eye Res. 2019, 73, 100762. [Google Scholar] [CrossRef]
- Liu, Y.-C.; Lin, M.T.-Y.; Mehta, J.S. Analysis of corneal nerve plexus in corneal confocal microscopy images. Neural Regen. Res. 2021, 16, 690–691. [Google Scholar] [CrossRef]
- Xu, J.; Chen, P.; Yu, C.; Liu, Y.; Hu, S.; Di, G. In vivo Confocal Microscopic Evaluation of Corneal Dendritic Cell Density and Subbasal Nerve Parameters in Dry Eye Patients: A Systematic Review and Meta-analysis. Front. Med. 2021, 8, 578233. [Google Scholar] [CrossRef]
- Maruoka, S.; Inaba, M.; Ogata, N. Activation of Dendritic Cells in Dry Eye Mouse Model. Investig. Opthalmol. Vis. Sci. 2018, 59, 3269–3277. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Kallinikos, P.; Berhanu, M.; O’Donnell, C.; Boulton, A.J.M.; Efron, N.; Malik, R. Corneal Nerve Tortuosity in Diabetic Patients with Neuropathy. Investig. Opthalmol. Vis. Sci. 2004, 45, 418–422. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Tepelus, T.C.; Chiu, G.B.; Huang, J.; Huang, P.; Sadda, S.R.; Irvine, J.; Lee, O.L. Correlation between corneal innervation and inflammation evaluated with confocal microscopy and symptomatology in patients with dry eye syndromes: A preliminary study. Graefe’s Arch. Clin. Exp. Ophthalmol. 2017, 255, 1771–1778. [Google Scholar] [CrossRef] [PubMed]
- Jalbert, I.; Stapleton, F.; Papas, E.; Sweeney, D.; Coroneo, M. In vivo confocal microscopy of the human cornea. Br. J. Ophthalmol. 2003, 87, 225–236. [Google Scholar] [CrossRef] [PubMed]
- Liu, Y.; Chou, Y.; Dong, X.; Liu, Z.; Jiang, X.; Hao, R.; Li, X. Corneal Subbasal Nerve Analysis Using In Vivo Confocal Microscopy in Patients with Dry Eye: Analysis and Clinical Correlations. Cornea 2017, 38, 1253–1258. [Google Scholar] [CrossRef]
- Ma, B.; Xie, J.; Yang, T.; Su, P.; Liu, R.; Sun, T.; Zhou, Y.; Wang, H.; Feng, X.; Ma, S.; et al. Quantification of Increased Corneal Subbasal Nerve Tortuosity in Dry Eye Disease and Its Correlation with Clinical Parameters. Transl. Vis. Sci. Technol. 2021, 10, 26. [Google Scholar] [CrossRef]
- Nguyen, C.Q.; Peck, A.B. Unraveling the Pathophysiology of Sjogren Syndrome-Associated Dry Eye Disease. Ocul. Surf. 2009, 7, 11–27. [Google Scholar] [CrossRef] [Green Version]
- Li, F.; Zhang, Q.; Ying, X.; He, J.; Jin, Y.; Xu, H.; Cheng, Y.; Zhao, M. Corneal nerve structure in patients with primary Sjögren’s syndrome in China. BMC Ophthalmol. 2021, 21, 211. [Google Scholar] [CrossRef]
- McNamara, N.A.; Ge, S.; Lee, S.M.; Enghauser, A.M.; Kuehl, L.; Chen, F.Y.-T.; Gallup, M.; McKown, R.L. Reduced Levels of Tear Lacritin Are Associated With Corneal Neuropathy in Patients With the Ocular Component of Sjögren’s Syndrome. Investig. Opthalmol. Vis. Sci. 2016, 57, 5237–5243. [Google Scholar] [CrossRef]
- Hillenaar, T.; van Cleynenbreugel, H.; Verjans, G.M.; Wubbels, R.J.; Remeijer, L. Monitoring the Inflammatory Process in Herpetic Stromal Keratitis: The Role of In Vivo Confocal Microscopy. Ophthalmology 2012, 119, 1102–1110. [Google Scholar] [CrossRef]
- Lanza, M.; Iaccarino, S.; Varricchi, G.; D’Errico, T.; Carnevale, U.A.G.; Bifani, M. Corneal confocal microscopy alterations in Sjögren’s syndrome dry eye. Acta Ophthalmol. 2016, 95, e366–e372. [Google Scholar] [CrossRef] [PubMed]
- Lee, O.L.; Tepelus, T.C.; Huang, J.; Irvine, A.G.; Irvine, C.; Chiu, G.B.; Sadda, S.R. Evaluation of the corneal epithelium in non-Sjögren’s and Sjögren’s dry eyes: An in vivo confocal microscopy study using HRT III RCM. BMC Ophthalmol. 2018, 18, 309. [Google Scholar] [CrossRef] [PubMed]
- Kawashima, M.; Sano, K.; Takechi, S.; Tsubota, K. Impact of lifestyle intervention on dry eye disease in office workers: A randomized controlled trial. J. Occup. Health 2018, 60, 281–288. [Google Scholar] [CrossRef] [PubMed]
- Giannaccare, G.; Pellegrini, M.; Sebastiani, S.; Bernabei, F.; Roda, M.; Taroni, L.; Versura, P.; Campos, E.C. Efficacy of Omega-3 Fatty Acid Supplementation for Treatment of Dry Eye Disease: A Meta-Analysis of Randomized Clinical Trials. Cornea 2019, 38, 565–573. [Google Scholar] [CrossRef]
- Leyva, I.M.; Molina-Leyva, A.; Bueno-Cavanillas, A. Efficacy of nutritional supplementation with omega-3 and omega-6 fatty acids in dry eye syndrome: A systematic review of randomized clinical trials. Acta Ophthalmol. 2017, 95, e677–e685. [Google Scholar] [CrossRef] [Green Version]
- Levy, O.; Labbé, A.; Borderie, V.; Hamiche, T.; Dupas, B.; Laroche, L.; Baudouin, C.; Bouheraoua, N. Increased corneal sub-basal nerve density in patients with Sjögren syndrome treated with topical cyclosporine A. Clin. Exp. Ophthalmol. 2017, 45, 455–463. [Google Scholar] [CrossRef] [Green Version]
- Iaccheri, B.; Torroni, G.; Cagini, C.; Fiore, T.; Cerquaglia, A.; Lupidi, M.; Cillino, S.; Dua, H.S. Corneal confocal scanning laser microscopy in patients with dry eye disease treated with topical cyclosporine. Eye 2017, 31, 788–794. [Google Scholar] [CrossRef] [Green Version]
- Giannaccare, G.; Buzzi, M.; Fresina, M.; Velati, C.; Versura, P. Efficacy of 2-Month Treatment With Cord Blood Serum Eye Drops in Ocular Surface Disease: An In Vivo Confocal Microscopy Study. Cornea 2017, 36, 915–921. [Google Scholar] [CrossRef]
- Chen, X.; Graham, J.; Petropoulos, I.N.; Ponirakis, G.; Asghar, O.; Alam, U.; Marshall, A.; Ferdousi, M.; Azmi, S.; Efron, N.; et al. Corneal Nerve Fractal Dimension: A Novel Corneal Nerve Metric for the Diagnosis of Diabetic Sensorimotor Polyneuropathy. Investig. Opthalmol. Vis. Sci. 2018, 59, 1113–1118. [Google Scholar] [CrossRef]
- Villani, E.; Garoli, E.; Termine, V.; Pichi, F.; Ratiglia, R.; Nucci, P. Corneal Confocal Microscopy in Dry Eye Treated with Corticosteroids. Optom. Vis. Sci. 2015, 92, e290–e295. [Google Scholar] [CrossRef] [Green Version]
- Chinnery, H.R.; Golborne, C.N.; Downie, L.E. Omega-3 supplementation is neuroprotective to corneal nerves in dry eye disease: A pilot study. Ophthalmic Physiol. Opt. 2017, 37, 473–481. [Google Scholar] [CrossRef] [PubMed]
- Mansoor, H.; Tan, H.C.; Lin, M.T.-Y.; Mehta, J.S.; Liu, Y.-C. Diabetic Corneal Neuropathy. J. Clin. Med. 2020, 9, 3956. [Google Scholar] [CrossRef] [PubMed]
- Clerck, E.E.B.D.; Schouten, J.S.; Berendschot, T.T.; Kessels, A.G.H.; Nuijts, R.M.M.A.; Beckers, H.J.M.; Schram, M.; Stehouwer, C.D.A.; Webers, C.A.B. New ophthalmologic imaging techniques for detection and monitoring of neurodegenerative changes in diabetes: A systematic review. Lancet Diabetes Endocrinol. 2015, 3, 653–663. [Google Scholar] [CrossRef]
- Perkins, B.A.; Lovblom, L.E.; Bril, V.; Scarr, D.; Ostrovski, I.; Orszag, A.; Edwards, K.; Pritchard, N.; Russell, A.; Dehghani, C.; et al. Corneal confocal microscopy for identification of diabetic sensorimotor polyneuropathy: A pooled multinational consortium study. Diabetologia 2018, 61, 1856–1861. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Liu, Y.-C.; So, W.; Wong, N.Q.; Tan, H.; Lin, M.Y.; Lee, I.Y.; Mehta, J. Diabetic corneal neuropathy as a surrogate marker for diabetic peripheral neuropathy. Neural Regen. Res. 2022, 17, 2172. [Google Scholar] [CrossRef] [PubMed]
- Lagali, N.S.; Allgeier, S.; Guimarães, P.; Badian, R.A.; Ruggeri, A.; Köhler, B.; Utheim, T.P.; Peebo, B.; Peterson, M.; Dahlin, L.B.; et al. Reduced Corneal Nerve Fiber Density in Type 2 Diabetes by Wide-Area Mosaic Analysis. Investig. Opthalmol. Vis. Sci. 2017, 58, 6318. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Utsunomiya, T.; Nagaoka, T.; Hanada, K.; Omae, T.; Yokota, H.; Abiko, A.; Haneda, M.; Yoshida, A. Imaging of the Corneal Subbasal Whorl-like Nerve Plexus: More Accurate Depiction of the Extent of Corneal Nerve Damage in Patients With Diabetes. Investig. Opthalmol. Vis. Sci. 2015, 56, 5417–5423. [Google Scholar] [CrossRef] [Green Version]
- Cozzini, T.; Piona, C.; Marchini, G.; Merz, T.; Brighenti, T.; Bonetto, J.; Marigliano, M.; Olivieri, F.; Maffeis, C.; Pedrotti, E. In vivo confocal microscopy study of corneal nerve alterations in children and youths with Type 1 diabetes. Pediatr. Diabetes 2021, 22, 780–786. [Google Scholar] [CrossRef]
- Petropoulos, I.N.; Ferdousi, M.; Marshall, A.; Alam, U.; Ponirakis, G.; Azmi, S.; Fadavi, H.; Efron, N.; Tavakoli, M.; Malik, R.A. The Inferior Whorl For Detecting Diabetic Peripheral Neuropathy Using Corneal Confocal Microscopy. Investig. Opthalmol. Vis. Sci. 2015, 56, 2498–2504. [Google Scholar] [CrossRef] [Green Version]
- Li, S.; Liu, D.; Li, L.; Li, Y.; Li, Q.; An, Z.; Sun, X.; Tian, H. Circulating Betatrophin in Patients with Type 2 Diabetes: A Meta-Analysis. J. Diabetes Res. 2016, 2016, 6194750. [Google Scholar] [CrossRef] [Green Version]
- Liang, H.; Randon, M.; Michee, S.; Tahiri, R.; Labbe, A.; Baudouin, C. In vivo confocal microscopy evaluation of ocular and cutaneous alterations in patients with rosacea. Br. J. Ophthalmol. 2016, 101, 268–274. [Google Scholar] [CrossRef] [PubMed]
- Gürdal, C.; Saraç, Ö.; Genç, I.; Kırımlıoğlu, H.; Takmaz, T.; Can, I. Ocular Surface and Dry Eye in Graves’ Disease. Curr. Eye Res. 2011, 36, 8–13. [Google Scholar] [CrossRef] [PubMed]
- Harrison, A.R.; Bothun, E.D.; Scheuer, R.A.; Lee, M.S. Update on thyroid eye disease and management. Clin. Ophthalmol. 2009, 3, 543–551. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Wu, L.-Q.; Mou, P.; Chen, Z.-Y.; Cheng, J.-W.; Le, Q.-H.; Cai, J.-P.; Wei, R.-L. Altered Corneal Nerves in Chinese Thyroid-Associated Ophthalmopathy Patients Observed by In Vivo Confocal Microscopy. Med. Sci. Monit. 2019, 25, 1024–1031. [Google Scholar] [CrossRef]
- Cheng, S.; Yu, Y.; Chen, J.; Ye, L.; Wang, X.; Jiang, F. In vivo confocal microscopy assessment of meibomian glands microstructure in patients with Graves’ orbitopathy. BMC Ophthalmol. 2021, 21, 261. [Google Scholar] [CrossRef]
- Yang, S.; Kim, W.; Kim, H.S.; Na, K.-S. Epidemiologic Survey Committee of the Korean Ophthalmologic Society Association Between Migraine and Dry Eye Disease: A Nationwide Population-Based Study. Curr. Eye Res. 2017, 42, 837–841. [Google Scholar] [CrossRef]
- Sarac, O.; Kosekahya, P.; Tasci, Y.Y.; Keklikoglu, H.D.; Deniz, O.; Erten, Ş.; Çağıl, N. The Prevalence of Dry Eye and Sjögren Syndrome in Patients with Migraine. Ocul. Immunol. Inflamm. 2017, 25, 370–375. [Google Scholar] [CrossRef]
- Situ, P.; Simpson, T.L.; Jones, L.W.; Fonn, D. Conjunctival and Corneal Hyperesthesia in Subjects with Dryness Symptoms. Optom. Vis. Sci. 2008, 85, 867–872. [Google Scholar] [CrossRef]
- Edvinsson, J.C.A.; Viganò, A.; Alekseeva, A.; Alieva, E.; Arruda, R.; De Luca, C.; D’Ettore, N.; Frattale, I.; Kurnukhina, M.; Macerola, N.; et al. The fifth cranial nerve in headaches. J. Headache Pain 2020, 21, 65. [Google Scholar] [CrossRef]
- Shetty, R.; Deshmukh, R.; Shroff, R.; Dedhiya, C.; Jayadev, C. Subbasal Nerve Plexus Changes in Chronic Migraine. Cornea 2017, 37, 72–75. [Google Scholar] [CrossRef]
- Tham, Y.-C.; Li, X.; Wong, T.Y.; Quigley, H.A.; Aung, T.; Cheng, C.-Y. Global Prevalence of Glaucoma and Projections of Glaucoma Burden through 2040: A systematic review and meta-analysis. Ophthalmology 2014, 121, 2081–2090. [Google Scholar] [CrossRef] [PubMed]
- Fechtner, R.D.; Godfrey, D.G.; Budenz, D.; Stewart, J.A.; Stewart, W.C.; Jasek, M.C. Prevalence of Ocular Surface Complaints in Patients With Glaucoma Using Topical Intraocular Pressure-Lowering Medications. Cornea 2010, 29, 618–621. [Google Scholar] [CrossRef] [PubMed]
- Servat, J.J.; Bernardino, C.R. Effects of Common Topical Antiglaucoma Medications on the Ocular Surface, Eyelids and Periorbital Tissue. Drugs Aging 2011, 28, 267–282. [Google Scholar] [CrossRef] [PubMed]
- Kucukevcilioglu, M.; Bayer, A.; Uysal, Y.; Altinsoy, H.I. Prostaglandin associated periorbitopathy in patients using bimatoprost, latanoprost and travoprost. Clin. Exp. Ophthalmol. 2013, 42, 126–131. [Google Scholar] [CrossRef]
- Rolle, T.; Spinetta, R.; Nuzzi, R. Long term safety and tolerability of Tafluprost 0.0015% vs Timolol 0.1% preservative-free in ocular hypertensive and in primary open-angle glaucoma patients: A cross sectional study. BMC Ophthalmol. 2017, 17, 136. [Google Scholar] [CrossRef] [Green Version]
- Mastropasqua, R.; Fasanella, V.; Brescia, L.; Oddone, F.; Mariotti, C.; Di Staso, S.; Agnifili, L. In Vivo Confocal Imaging of the Conjunctiva as a Predictive Tool for the Glaucoma Filtration Surgery Outcome. Investig. Opthalmol. Vis. Sci. 2017, 58, 114–120. [Google Scholar] [CrossRef]
- Amar, N.; Labbé, A.; Hamard, P.; Dupas, B.; Baudouin, C. Filtering Blebs and Aqueous Pathway: An Immunocytological and In Vivo Confocal Microscopy Study. Ophthalmology 2008, 115, 1154–1161.e4. [Google Scholar] [CrossRef]
- Agrawal, A.; Agrawal, S.; Gupta, S. Role of Dendritic Cells in Inflammation and Loss of Tolerance in the Elderly. Front. Immunol. 2017, 8, 896. [Google Scholar] [CrossRef]
- Sacchi, M.; Agnifili, L.; Brescia, L.; Oddone, F.; Villani, E.; Nucci, P.; Mastropasqua, L. Structural imaging of conjunctival filtering blebs in XEN gel implantation and trabeculectomy: A confocal and anterior segment optical coherence tomography study. Graefe’s Arch. Clin. Exp. Ophthalmol. 2020, 258, 1763–1770. [Google Scholar] [CrossRef]
- Herretes, S.; Ross, D.B.; Duffort, S.; Barreras, H.; Yaohong, T.; Saeed, A.M.; Murillo, J.C.; Komanduri, K.V.; Levy, R.B.; Perez, V.L. Recruitment of Donor T Cells to the Eyes During Ocular GVHD in Recipients of MHC-Matched Allogeneic Hematopoietic Stem Cell Transplants. Investig. Opthalmol. Vis. Sci. 2015, 56, 2348–2357. [Google Scholar] [CrossRef] [Green Version]
- Tepelus, T.C.; Chiu, G.B.; Maram, J.; Huang, J.; Chopra, V.; Sadda, S.R.; Lee, O.L. Corneal features in ocular graft-versus-host disease by in vivo confocal microscopy. Graefe’s Arch. Clin. Exp. Ophthalmol. 2017, 255, 2389–2397. [Google Scholar] [CrossRef]
- Niederer, R.; Perumal, D.; Sherwin, T.; McGhee, C.N.J. Corneal Innervation and Cellular Changes after Corneal Transplantation: An In Vivo Confocal Microscopy Study. Investig. Opthalmol. Vis. Sci. 2007, 48, 621–626. [Google Scholar] [CrossRef] [Green Version]
- Patel, S.V.; Erie, J.C.; McLaren, J.W.; Bourne, W.M. Keratocyte and subbasal nerve density after penetrating keratoplasty. Trans. Am. Ophthalmol. Soc. 2007, 105, 180–189. [Google Scholar]
- Al-Aqaba, M.A.; Otri, A.M.; Fares, U.; Miri, A.; Dua, H.S. Organization of the Regenerated Nerves in Human Corneal Grafts. Am. J. Ophthalmol. 2012, 153, 29–37.e4. [Google Scholar] [CrossRef]
- Ogawa, Y. Sjögren’s Syndrome, Non-Sjögren’s Syndrome, and Graft-Versus-Host Disease Related Dry Eye. Investig. Opthalmol. Vis. Sci. 2018, 59, 71–79. [Google Scholar] [CrossRef]
- Dikmetas, O.; Kocabeyoglu, S.; Mocan, M.C. The Association between Meibomian Gland Atrophy and Corneal Subbasal Nerve Loss in Patients with Chronic Ocular Graft-versus-host Disease. Curr. Eye Res. 2021, 46, 796–801. [Google Scholar] [CrossRef]
- Stapleton, F.; Keay, L.; Jalbert, I.; Cole, N. The Epidemiology of Contact Lens Related Infiltrates. Optom. Vis. Sci. 2007, 84, 257–272. [Google Scholar] [CrossRef]
- Poggio, E.C.; Glynn, R.J.; Schein, O.D.; Seddon, J.M.; Shannon, M.J.; Scardino, V.A.; Kenyon, K.R. The Incidence of Ulcerative Keratitis among Users of Daily-Wear and Extended-Wear Soft Contact Lenses. N. Engl. J. Med. 1989, 321, 779–783. [Google Scholar] [CrossRef]
- Chalmers, R.L.; Keay, L.; McNally, J.; Kern, J. Multicenter Case-Control Study of the Role of Lens Materials and Care Products on the Development of Corneal Infiltrates. Optom. Vis. Sci. 2012, 89, 316–325. [Google Scholar] [CrossRef]
- Golebiowski, B.; Chao, C.; Bui, K.A.; Lam, W.Y.W.; Richdale, K.; Stapleton, F. Effect of age and contact lens wear on corneal epithelial dendritic cell distribution, density, and morphology. Contact Lens Anterior Eye 2019, 43, 84–90. [Google Scholar] [CrossRef]
- Saliman, N.H.; Morgan, P.; MacDonald, A.S.; Maldonado-Codina, C. Subclinical Inflammation of the Ocular Surface in Soft Contact Lens Wear. Cornea 2019, 39, 146–154. [Google Scholar] [CrossRef]
- Steele, K.R.; Szczotka-Flynn, L. Epidemiology of contact lens-induced infiltrates: An updated review. Clin. Exp. Optom. 2017, 100, 473–481. [Google Scholar] [CrossRef] [Green Version]
- Lum, E.; Golebiowski, B.; Swarbrick, H.A. Reduced Corneal Sensitivity and Sub-Basal Nerve Density in Long-Term Orthokeratology Lens Wear. Eye Contact Lens Sci. Clin. Pract. 2017, 43, 218–224. [Google Scholar] [CrossRef]
- Nombela-Palomo, M.; Felipe-Márquez, G.; Teus, M.; Hernández-Verdejo, J.L.; Bona, A.N. Long-Term Impacts of Orthokeratology Treatment on Sub-Basal Nerve Plexus and Corneal Sensitivity Responses and Their Reversibility. Eye Contact Lens Sci. Clin. Pract. 2018, 44, 91–96. [Google Scholar] [CrossRef]
- Turuwhenua, J.T.; Patel, D.; McGhee, C.N. Fully Automated Montaging of Laser Scanning In Vivo Confocal Microscopy Images of the Human Corneal Subbasal Nerve Plexus. Investig. Opthalmol. Vis. Sci. 2012, 53, 2235–2242. [Google Scholar] [CrossRef] [Green Version]
- Badian, R.A.; Allgeier, S.; Scarpa, F.; Andréasson, M.; Bartschat, A.; Mikut, R.; Colonna, A.; Bellisario, M.; Utheim, T.P.; Köhler, B.; et al. Wide-field mosaics of the corneal subbasal nerve plexus in Parkinson’s disease using in vivo confocal microscopy. Sci. Data 2021, 8, 306. [Google Scholar] [CrossRef]
- Bohr, A.; Memarzadeh, K. The rise of artificial intelligence in healthcare applications. In Artificial Intelligence in Healthcare; Academic Press: Cambridge, MA, USA, 2020; Chapter 2; pp. 25–60. [Google Scholar] [CrossRef]
Area of Study | Authors | Main Contribution to Literature | Design | Sample Size (Eyes) | Source of Participants | No. of Visits | HRT | Main Outcomes | Main Findings | Limitations |
---|---|---|---|---|---|---|---|---|---|---|
Immune cellular metrics of inflammation | Qazi Y. | Only study which uses IVCM-based immune-cellular metrics to assess the inflammation of MGD. | Cross-sectional, retrospective | 29 | Outpatient | 1 | HRT III-RCM |
| EIC and IGIC increased in highly symptomatic patients that have minimal corneal staining and correlate with symptoms and clinical signs. | A cross-sectional study does not demonstrate that the progression of MGD causes increases in immune cells. Small sample size. |
Evaluation of corneal layers in MGD | Azizi S. | Evaluating individual corneal layers using IVCM | Single-center, prospective | 92 | Outpatient | 1 | HRT III-RCM |
| Basal epithelial cell density reduced, the area increased, and stromal nerve thickness greater in the MGD group. | Study repeats the older methodology (no new findings) |
Classification in the diagnosis of MGD | Randon M. | Using IVCM as a new way to classify the various pathophysiological system for MGD | Cross-sectional, retrospective | 115 | Outpatient | 1 | HRT II-RCM |
| Strong correlation between IVCM score (Type 0 normal MG; type 1 obstructed MG without inflammation or fibrosis; type 2 MG inflammation without fibrosis; type 3 MG fibrosis), and meibography score. | Study about the grading severity of MGD needs more studies to confirm accuracy. |
MGD with different symptoms | Zhao H. | Attempted to differentiate symptoms of MGD using IVCM | Cross-sectional, retrospective | 60 | Outpatient | 1 | HRT II-RCM |
| More severe symptoms had more significant fibrosis and a severe decrease in the size of MG acinar units. DED symptoms negatively correlated with confocal microscopic parameters and positively correlated with conjunctival inflammatory cells and Langerhans cells | Unable to test MG lipid and inflammatory factors which could contribute to DED. |
Area of Study | Authors | Main Contribution to Literature | Design | Sample Size | Source of Participants | No. of Visits | HRT | Main Outcomes | Main Findings | Limitations |
---|---|---|---|---|---|---|---|---|---|---|
Imaging of POV in DED | Ghouali | In all quadrants, fewer POVs were detected in DED patients than in normal subjects | Prospective case-control | 163 | Outpatient | 1 | HRT II-RCM | POV found predominantly in superior (p < 0.001) and inferior (p < 0.001) quadrants compared to nasal and temporal quadrants | En-face SD-OCT showed POV as a radially oriented network located in the superficial corneoscleral limbus, with a good correlation with IVCM features | Depth of analysis (70 μm below the corneal/conjunctiva surface) might not capture the entire POV structure. |
Corneal Sub-basal Nerve Plexus in DED (New Fully Automated System) | Giannaccare | ACC Metrics detected SNP alterations in DED, good diagnostic performance in discriminating DED. | Cross-sectional | 69 | Outpatient | 1 | HRT-RCM | CNBD CNFL CNFW | Lower CNBD, CNFL & higher CNFW in DED compared to controls | Small sample size ACC metrics cannot analyze and quantify nerve tortuosity, a well-recognized metric affected in DED |
DED and Low Sub-basal Nerve Density and Corneal Endothelial Cell Loss | Kheirkhah | DED associated with accelerated corneal endothelial cell loss | Retrospective 33.2 ± 10.2 months | 40 | Outpatient | 2 (baseline, next visit) | HRT III-RCM | Densities of corneal endothelial cells and sub-basal nerve | Initial visit DED: lower densities of corneal endothelial cells and sub-basal nerves than control Endothelial cell loss negative correlation with initial sub-basal nerve density | Retrospective design, small sample size, did not evaluate the morphology of endothelial cells Only central CECD was measured. |
Evaluation of Objective Visual Quality in Dry Eye Disease and Corneal Nerve Changes. | Ma, Jiahui | Longer and wider corneal nerves were associated with better objective visual quality in DED | Prospective study | 98 | Outpatient | 1 | Not specified | CNFL, objective scatter index, mean objective scattering index, modulation transfer function, Strehl ratio. | Patients with longer and wider corneal nerves had better objective visual quality | No control group. Changes in Langerhans cells not summarized. Small sample size |
Quantification of Corneal Sub-basal Nerve Tortuosity in DED and Its Correlation With Clinical Parameters | Ma, Baikai | New parameter: Aggregated measure of tortuosity (Tagg) for quantification of corneal sub-basal nerve tortuosity. | Cross-sectional case-control | 49 | Outpatients | 1 | RCM | Tagg higher in DED than controls (p < 0.001). Tagg correlated with OSDI (r = 0.418) & negatively correlated with BUT | Higher Tagg may be linked to ocular discomfort, visual function disturbance, and tear film instability | Excluded images with DCs and obvious neuromas because DCs co-segmented with nerves |
Corneal Sub-basal Nerve Analysis in DED and Clinical Correlations | Liu Yan | IVCM is a useful tool to evaluate corneal changes in DED, such as in sub-basal nerves and Langerhans cells (LCs) | Cross-sectional study | 107 | Outpatient | 1 | HRT II-RCM | CNFL CNFT CNFW | Langerhans cells no. not correlated with symptoms. CNFL negatively correlated with sensitivity to light; CNFW positively correlated with OSDI, pain, blurred vision; CNFT positively correlated with sensitivity to light | No healthy controls. Cross-sectional study. |
IVCM in Primary Sjögren Syndrome and Sicca Syndrome Patients | Joana C. | Using IVCM to diagnose and differentiate immune-mediated DED from other forms of DED | Cross-sectional, retrospective | 136 | Outpatient | 1 | HRT III-RCM | SNP
| pSS and non-SS sicca pts had lower corneal SNP plexus density and length, increased tortuosity compared to healthy controls, unable to differentiate between pSS and non-SS | Some patients in immune-mediated DED groups did not meet the criteria for DED. |
Ocular Surface Alterations in Patients With Fibromyalgia | Turan E. | First study to evaluate corneal microstructures in FM. | Cross-sectional, retrospective | 76 | Outpatient | 1 | HRT III-RCM |
| Basal epithelial cell density, total nerve density, long new fibers, total no. of nerves lower in patients with FM. | Small sample size. |
IVCM in SSDE | Michele L. | Using light backscattering as a parameter in IVCM to evaluate SSDE | Cross-sectional, retrospective | 110 | Outpatient | For 6 cont. months | HRT III-RCM | Light backscattering | LB is higher in patients with SSDE, which is postulated to be due to higher levels of inflammation in SSDE. | Cross-sectional study does not prove causation. |
Corneal epithelium in SSDE vs. NSDE | Olivia L. | Assessing reproducibility and reliability of other studies on the same topic. | Cross-sectional, prospective | 78 | Outpatient | 1 | HRT III-RCM | Superficial, basal, outer wing, and inner wing epithelial cell density |
| Cross-sectional study does not prove causation. |
Cornea nerve structure with primary SSDE vs. NSDE | Fangting L. | Evaluate IVCM morphology of corneal SNP and its relationship with clinical parameters | Cross-sectional, prospective | 42 | Outpatient | 1 | HRT III-RCM | SNP
|
| Small sample size, area selected for IVCM analysis is not representative of the whole plexus |
Tear lacritin levels in patients with SSDE | Nancy M. | First study to inv association between tear lacritin levels and SS patients | Cross-sectional, prospective | 20 | Outpatient | 1 | Nidek Confoscan 4 | SNP
|
| Small sample size, focus of study is not on IVCM |
Corneal Innervation, Inflammation, and Symptoms in DED | Tepelus | NSDE and SSDE: alterations in corneal innervation and increased DCs. Corneal nerve density and reflectivity are correlated with OSDI. | Prospective case-control study | 78 | Outpatient | 1 | HRT III-RCM | CNBD CNFT, Reflectivity of corneal nerves, CDCD | CNBD decreased in SSDE & NSDE, Increased CNFT & decreased reflectivity in both. DCs increased in SSDE & NSDE compared to controls Correlations between DNF & DC (r = −0.57), between DNF & OSDI (r = −0.91) and between RNF & OSDI (r = −0.75). | Relatively small no. of patients Topical and systemic corticosteroids have a potential effect on epithelial DC density and OSDI Most participants females—results may not be extrapolated to male patients. |
Proinflammatory Markers, Chemokines, and Enkephalin in DED | Pierre Nicolle | DED patients have significantly higher corneal DC density compared to controls | Prospective case-control study | 47 | Outpatient | 1 | HRT-RCM | Sub-basal nerve density CDCD | Sub-basal nerve density was significantly lower in DED compared to controls; DED patients had a significantly higher corneal DC density compared to controls. | Not all participants had IVCM in both eyes. Low quantity of mRNA in some impressions. No protein level markers nor immune composition. |
Correlation of Corneal Immune Cell Changes with Clinical Severity in DED | Aggarwal | DC density and morphology correlated with DED severity, DC density increased in mild DED, morphological changes in severe DED. | Retrospective, cross-sectional | 349 | Outpatient | 1 | HRT III-RCM | DCD Size Morphology | DC density is higher in DED compared to controls. Morphologically, the number of dendrites, DC size, and field were significantly larger in DED than in controls. | Retrospective. Only analyzed central corneal images. |
Tear Nociception-Associated Factors, Cornea DCD in DED | Khamar | Altered tear fluid soluble factors associated with ocular surface discomfort, TBUT, Schirmer’s test, and cornea DCD | Case-control cross-sectional | 80 | Outpatient | 1 | HRT II-RCM | Cornea DCD, SNP features | Cornea DCD is significantly higher in DED patients. No significant difference was observed in SNP features. | Cross-sectional design |
Area of Study | Authors | Main Contribution to Literature | Design | Sample Size | Source of Participant | No. of Visits | HRT | Main Outcomes | Main Findings | Limitations |
---|---|---|---|---|---|---|---|---|---|---|
Corneal SNP density in SSDE treated with cyclosporin A | Ora L. | Evaluate SNP changes in SSDE treated with cyclosporin A | Longitudinal, prospective, observational | 45 | Outpatient | 2 (base, 6 months) | HRT III-RCM |
| SNP density sig increased after CsA, a/w decreased tortuosity, and DCs number | Lack of placebo group and repeated IVCM in healthy group 6 months later. |
2-month treatment of CBS eye drops in ocular surface disease | Giannaccare G. | Reported corneal cell morphology and corneal nerves after CBS therapy | Prospective, observational, cross-sectional | 20 | Outpatient | 1 | HRT III-RCM |
|
| Cause of DED in 20 patients was different |
DED treated with different sources of homologous eye drops | Giannaccare G. | RCT to investigate the difference in the effect of allo-PBS and CBS eye drops on corneal nerve morphology | Randomized, double-blinded RCT | 30 | Outpatient | 2 (base, 30 days) | HRT III-RCM |
|
| Small sample size, follow-up time too short to draw a conclusion on eye drop efficacy |
Patients with DED treated with topical cyclosporin | Iaccheri B. | No studies have yet evaluated topical cyclosporine on IVCM parameters in DED | Prospective, observational, cross-sectional | 42 | Outpatient | 4 (base, 1, 3, 6 months) | HRT II-RCM |
|
| Small sample size, causes of DED in the patient group, not constant |
Mild DED Trial with artificial tears or steroids and relationship to corneal DCs | Li Bei | Topical steroids can reduce corneal DCs | Case-control | 72 | Outpatient | 1 | Not specified | Tear and conjunctival cytokines, amount of DCs | More DCs in cornea epithelium of dry eye s with symptoms outweighing signs than common mild dry eye and control groups. After glucocorticoid treatment, the number of DCs significantly decreased | IVCM findings are limited to DCs |
Efficacy of 2% Topical Rebamipide on Conjunctival Squamous Metaplasia and Goblet Cell Density in DED | Simsek | Topical use of 2% rebamipide for 3 months associated with improvements in ocular surface differentiation due to mucosal changes | Prospective interventional study | 15 | Outpatient | 2 (baseline, 3 months) | HRT II RCM | Evaluation of nucleocytoplasmic ratios and corneal ECs | Significant improvements in mean corneal epithelial cell density and nucleocytoplasmic ratios after treatment. | Small sample size |
Omega-3 on corneal nerves in DED | Chinnery H. | RCT to investigate the effect of omega-3 on nerve parameters in DED | Randomized, double-blinded, RCT | 12 | Outpatient | 2 (base, 90 days) | HRT III-RCM | CNFD, CNFL, CNBD, CTBD, CNFW, and CNFA Hyperreflective DCs |
| Small sample size |
IVCM in DED after autologous eye drop | Mahelkova G. | Added to the current literature of IVCM findings after topical therapies on DED | Prospective, observational, cross-sectional | 26 | Outpatient | 2 (base, 3 month) | SSCM, Confoscan 3, NIDEK Technologie, Padua, Italy |
|
| Small sample size, no control group to compare against |
Combined hyaluronic acid (HA) and coenzyme Q10 eyedrops vs. HA alone eyedrops in DED | Postorino E. | Added to IVCM findings in the dry eye after novel medication (XLHA and CoQ10)—the study of epithelial cell reflectivity, keratocytes, stromal matrix parameters | Randomized, single-blinded RCT | 40 | Outpatient | 4 (base, 15, 30, 90 days) | Confoscan 4 confocal microscope (Nidek Technologies) |
|
| Small sample size |
Ocular nebulization of Vitamin B12 vs. oxytocin in DED | Yang J. | First to report IVCM changes after nebulization in ophthalmology | Randomized, double-blinded RCT | 38 | Outpatient | 3 (base, 1, 3 month) | HRT III-RCM |
|
| Ages in both groups different, no control group |
Area of Study | Authors | Main Contribution to Literature | Design | Sample Size | Source of Participants | No. of Visits | HRT | Main Outcomes | Main Findings | Limitations |
---|---|---|---|---|---|---|---|---|---|---|
Corneal nerve alterations in children and youths with T1DM | Tiziano C | Early signs of corneal nerve degeneration were found in children and youths with T1DM | Retrospective case-control study | 201 | Outpatient | 1 | HRT III-RCM | CNFL CNFD CNBD CTBD CNFrD | All IVCM parameters, except CTBD, were significantly lower in the T1D patients. Glycometabolic control (HbA1c, visit-to-visit HbA1c variability, and mean HbA1c) and blood pressure were inversely correlated with IVCM parameters. | Small sample size; sample had European ancestry, so results cannot necessarily be extended to children and adolescents with other ethnic backgrounds. |
Reduced Corneal Nerve Fiber in T2DM | Neil S Lagali | Wide-area mosaic images provide reference values for mosaic CNFL (mCNFL) and whorl CNFL (wCNFL) and reveal a progressive degeneration of the SBP with increasing duration of type 2 diabetes. | Population-based study | 163 | Outpatient | 1 | HRT III-RCM | mCNFL Apical wCNFD | mCNFL in T2DM reduced relative to non-diabetic subjects Lower mCNFL is associated with diabetes and increased HbA1c levels Apical wCNFD was unaffected by diabetes or HbA1c Global SNP patterns revealed marked degeneration of secondary nerve fiber branches outside the whorl region in long-duration diabetes. | Small sample size |
DC maturation in corneal epithelium associated with TNF receptor superfamily member 9 | Neil S Lagali | Develop a non-invasive means to monitor the status of inflammatory DC subsets in the corneal epithelium as a potential biomarker for the onset of inflammation in T2DM | Cohort study | 81 | Outpatient | 1 | HRT III-RCM | Quantification of DCs | With the onset of diabetes, the proportion of mature, antigen-presenting DCs increased and became organized in clusters. TNF receptor superfamily member 9 (TNFRSF9) is associated with the observed maturation of DCs from an immature to mature antigen-presenting phenotype. | Small cohort size, narrow focus on the relationship between systemic markers of inflammation and corneal DCs |
Sub-basal nerves in wide-area corneal nerve plexus mosaics in T2DM | Reza A Badian | Sub-basal nerve degeneration in T2DM can vary according to anatomic location | Cross-sectional study | 163 | Outpatient | 1 | HRT III-RCM | SNP CNFL | In long-term T2DM, nerve density in the left superior sector of SNP decreased while that in the central superior SNP increased relative to healthy subjects with normal glucose tolerance CNFL is not affected by diabetes | Cross-sectional nature |
Imaging of Corneal Sub-basal Whorl-like Nerve Plexus | Tsugiaki Utsunomiya | IVCM measurements of whorl-like patterns may accurately define the extent of corneal nerve damage to monitor diabetic peripheral neuropathy. | Observational study | 68 | Outpatient | 1 | HRT III-RCM | CNFL | Total CNFL is significantly shorter in DM group than in the control group and decreases with the progression of diabetic retinopathy, nephropathy, neuropathy, and decreased corneal sensation. | Small no of patients, captured a whorl-like pattern in half of the subjects (visual fixation unstable with fatigue)’ T1DM and T2DM subjects combined with analysis |
IVCM of Corneal Nerves: Ocular Biomarker for Peripheral and Cardiac Autonomic Neuropathy in T1DM | Stuti L Misra | Correlation of corneal SNP density with total neuropathy score suggests that reduced corneal nerve density reflects peripheral neuropathy in diabetes. | Case-control study | 93 | Outpatient | 1 | HRT II-RCM | Corneal SNP density Corneal sensitivity | Corneal SNP density and corneal sensitivity were significantly lower in diabetes compared to controls. A modest negative correlation between total neuropathy score and SBN density was observed. | Sub-basal nerve branching and tortuosity were not considered nor analyzed |
Epithelial changes with corneal punctate epitheliopathy and correlation with time to healing in T2DM | Jing-Hao Qu | Increased LC and decreased SNP in T2DM with corneal punctate epitheliopathy | Retrospective study | 160 | Outpatient | 1 | HRT III-RCM | Density of BEC, SNP, and LC | LC density, SNP density, and BEC density were reduced in the T2DM group compared with controls. LC density in the T2DM group showed a negative correlation with SNP density. SNP density in the T2DM group showed a positive correlation with BEC density. BEC density in the T2DM group showed a negative correlation with healing time. | IVCM images only from the first patient visit and no post-treatment images for comparison. Glycemic control data was not collected in T2DM patients. |
Association between alterations of corneal SNP and long-term glycemic variability | Marco P | HbA1c and disease duration were independent predictors of damage to SNP in T1DM. | Consecutive cross-sectional study | 40 | Outpatient | 1 | HRT-RCM | CNFD CNFL CNFrD CTBD CNFA CNFW | Diabetes duration and all-time SD of HbA1c were independently associated with CNFD, CNFL, and CNFrD. Analysis of the association among IVCM parameters and specific subtypes of diabetic neuropathy showed that altered cold sensitivity was independently associated with CNFD. | Small no of patients, lack of longitudinal IVCM analysis, included only T1DM |
Ocular and Cutaneous Rosacea | Liang, Hong | IVCM features of rosacea patients combined with quantification of Demodex | Case-control cross-sectional study | 44 | Outpatient | 1 | HRT-RCM | MG (IVCM-MG) cheek (IVCM-Cheek) alterations, Demodex counts: IVCM-MG-Dex IVCM-Cheek-Dex | IVCM-MG correlated with IVCM-Cheek IVCM-MG-Dex correlated with IVCM-Cheek-Dex | cannot image deeper structure no normal controls |
Sub-basal Nerve Plexus Changes in Chronic Migraine | Shetty, Rohit, | Changes in SNPP support the role of the trigeminal system in the pathogenesis of ocular symptoms in migraine | Cross-sectional study | 84 | Outpatient | 1 | HRT-RCM II | CNFD NFL CNBD CTBD CNFA Average CNFW | SNPP: a significant decrease in CNFL, CTBD, CNBD, and CNFA in migraine with photophobia | Changes during ictal period not done Small sample |
Chinese TAO | Wu LQ | Abnormal corneal sub-basal nerves observed in active and inactive Chinese TAO | Cross-sectional study | 58 | Outpatient | 1 | HRT III-RCM | CNFD CNBD CNFL CTBD CNFA CNFW ACNFrD | SNP parameters of TAO decreased compared to controls; correlations between CNFD, CNBD, CNFL, CTBD, CNFA, and ACNFrD | Small sample size No adjustment for dry eye or tear function |
Meibomian Glands structure in Graves’ Orbitopathy | Cheng S | IVCM found obstruction and inflammation in MG of GO patients | Cross-sectional observational study | 142 | Outpatient | 1 | HRT III-RCM | MAD, MALD, MASD MOA, MAI, MSR, AWI, API, MG fibrosis. | Compared to controls, GO: lower MOA, MAD; greater MALD, MASD, MAI, MSR, and MG fibrosis Active GO: higher MAI, AWI, & API, Inactive GO: higher MSR and MG fibrosis GO: AWI and API positively correlated with CAS, MG fibrosis negatively correlated with CAS. | Control group is not representative of the healthy population—some had dry eye symptoms and inadequate MG performance |
Corneal changes in Mucous Membrane Pemphigoid (MMP) | Tepelus | Microstructural corneal changes in MMP | Prospective single-center cross-sectional study | 40 | Outpatient | 1 | HRT III-RCM | Morphology of corneal epithelial layers, stroma, and endothelium, corneal nerves, and presence of DCs | Decreased corneal nerve density and elevated DC in non-end-stage MMP compared with controls. | Small sample size |
Corneal Nerve in Parkinson’s Disease. | Misra, Stuti L. | Significant reduction in corneal SNP density in Parkinson’s, which is associated with cognitive dysfunction | Cross-sectional study | 30 | Outpatient | 1 | HRT II-RCM | Corneal SNP density | Corneal SNP density markedly reduced in Parkinson’s compared with controls | Limited sample size mild disease excluded |
Area of Study | Authors | Main Contribution to Literature | Design | Sample Size | Participants | No. of Visits | HRT | Main Outcomes | Main Findings | Limitations |
---|---|---|---|---|---|---|---|---|---|---|
Structural Imaging of Conjunctival Filtering Blebs in XEN Gel Implantation and Trabeculectomy | Sacchi | First paper to use IVCM on epithelial cysts and a hypo-reflective bleb wall | Retrospective, cross-sectional, observational study | 52 | Outpatient | 2 (baseline, 6 months) | HRT III-RCM | MMD, MMA, SMR | MMA and SMR values were lower in the XEN gel implantation compared with trabeculectomy | Retrospective, small sample size, inclusion of only completing successful filtering blebs |
Prospective, Masked, 36 Months Study on Glaucoma Patients Medically Treated with PF or Preserved Monotherapy | Rossi | PF-tafluprost formulation does not alter corneal structures after 36 months of topical daily therapy | Prospective, Masked Study | 93 | Outpatient | 7 (Baseline and every 6 months for 3 years) | Confoscan 4 (Nidek technologies) | Activation of keratocytes, number of sub-basal plexus nerve fibers, tortuosity, number of bead-like formations, endothelial cellular density. | At baseline, keratocyte activation similar in the 3 groups Over months, naïve patients treated with PF-tafluprost reduced keratocyte activation. Sub-basal nerves increase in patients switched to PF-tafluprost | Investigation limited to the center of the cornea, different results were obtained by inspecting the corneal periphery Limited sample size |
Long Term Safety and Tolerability of Tafluprost 0.0015% vs. Timolol 0.1% Preservative-Free in Ocular Hypertensive and in Primary Open-Angle Glaucoma Patients: A Cross-Sectional Study | Rolle, Teresa | Both therapy: show alterations in corneal microstructure but no side effects on tear function. | Retrospective, single-masked, observational, cross-sectional study | 108 | Outpatient | 1 | HRT II-RCM | Basal EC density Stromal reflectivity (keratocytes activation) No. sub-basal nerves, Sub-basal nerve tortuosity, Sub-basal nerve reflectivity, Endothelial cell density. | Tafluprost: higher OSDI score, basal EC density, stromal reflectivity, sub-basal nerves tortuosity, and less number of sub-basal nerves than control Timolol: higher OSDI, basal EC density, stromal reflectivity, and sub-basal nerve tortuosity, less no. of sub-basal nerves than controls. | Only examine the central cornea, Retrospective nature |
IVCM of Conjunctiva as a Predictive Tool for the Glaucoma Filtration Surgery Outcome | Mastropasqua | Preoperative DCD, GCD, SMR are parameters correlated with filtration surgery outcome, with DCD presenting the strongest correlation | Prospective, single-center, case-control | 81 | Outpatient | 2 (baseline, 12 months) | HRT III-RCM | Conjunctival DCD, GCD, SMR | 12 month IOP reduction negatively correlated with baseline DCD and SMR and positively with GCD IVCM of the conjunctiva may represent an imaging tool to predict the surgical success in glaucoma. | SMR is arbitrary. Unsure if DCD, GCD, and SMR are different before therapy between groups. Possible normal interindividual variability in DCs and GCs, and in the stromal density of conjunctiva |
Uveo-Scleral Outflow Pathways after UCCC in Refractory Glaucoma | Mastropasqua | UCCC induced modifications of sclera and conjunctiva structures | Prospective interventional, case-control study | 44 | Outpatient | 2 (baseline, 1 month) | HRT III-RCM | Area of conjunctival microcysts (MMD: cysts/mm2; MMA: µm2) at IVCM | MMA and MMD increased in both groups of UCCC (4 s and 6 s), with values higher in 6 s UCCC | Cases and controls differ because controls did not have refractory glaucoma due to ethical concerns; Did not evaluate the intra-subject agreement. |
In Vivo Distribution of Corneal Epithelial DCs in Medically Controlled Glaucoma Patients (MCGP) | Mastropasqua | DCs increase in the entire cornea, with a higher density at the limbus, may induce glaucoma-related ocular surface disease | Retrospective observational study | 80 | Outpatient | 1 | HRT III-RCM | Limbal and central DC density, DCs morphology and distribution. | DC density is higher in glaucoma & DED than in controls DC density is higher in patients taking preserved than patients taking PF drops DC density correlated with staining | Retrospective nature; Did not investigate other corneal features such as sub-basal nerve plexus or the superficial epithelial layers. |
The Ocular Surface after Successful Glaucoma Filtration Surgery | Agnifili | Whole ocular surface system objectively improved after completely successful glaucoma filtration surgery. | Prospective case-control study | 54 | Outpatient | 2 (baseline, at 6 months) | HRT III-RCM | GCD, limbal DCD, SCNI; MGD, MGI, and HLA-DR positivity. | At the 6th month, surgical group: GCD increase, and limbal DCD, SCNI, MGI, HLA-DR, OSDI decrease OSDI correlated with GCD, MGI, SCNI, limbal DCD, & HLA-DR | Cannot ascertain whether changes are due to drug discontinuation, topical steroids, or both. Did not analyze structural corneal nerve parameters; MMC has a cytotoxic effect No MMC-independent glaucoma surgery as a comparison. |
Meibomian Gland Features and Conjunctival Goblet Cell Density in Glaucomatous Patients Controlled With PTFCs | Agnifili | PTFCs were less toxic towards MGs and goblet cells compared with the L + T unfixed combination, with PF-BTFC presenting the most tolerated profile. | Case-control cross-sectional study | 90 | Outpatient | 1 | HRT III-RCM | MMAD, MMAA, InI, InAW, GCD | IVCM documented lower GCD, MMAD, and MMAA, and greater InI and InAW in glaucoma patients compared with controls. | Cross-sectional study Cannot provide MG and GC status before initiation of therapy. Possible unreported/transient ocular surface problems. Limited sample and for grouping. |
Conjunctival GCs in Medically-Controlled Glaucoma | DI Staso | Glaucoma therapy leads to a marked reduction of GCs | Case-control, cross-sectional, non-interventional study | 72 | Outpatient | 1 | HRT III-RCM | GCD | GCD was reduced in both glaucoma groups and those with DED compared to healthy controls, markedly lower in group 2 compared to group 1. GCD was not different between DED and group 2. Negative correlation between GCD with OSDI and with TBUT | Did not allow evaluation of the racial differences in the GC population. Baseline GC before therapy unavailable, Did not consider patients controlled with three medications. |
Area of Study | Authors | Main Contribution to Literature | Design | Sample Size | Participants | No. of Visits | HRT | Main Outcomes | Main Findings | Limitations |
---|---|---|---|---|---|---|---|---|---|---|
DED with and without chronic GVHD | Kheirkhah A | Only study concludes that symptomatology may be linked to local disease rather than the underlying systemic disease. | Retrospective, cross-sectional | 52 | Outpatient | 1 | HRT III-RCM |
| No significant differences in IVCM parameters for both groups. | GVHD group treated with anti-inflammatory medications, lowering inflammatory changes. |
Corneal features in ocular GVHD | Tepelus TC | IVCM revealed distinct microstructural changes in the corneas of patients with oGVHD and DED | Cross-sectional, observational | 33 | Population | 1 | HRT III-RCM |
| Superficial EC density, basal cell density are lower in oGVHD and DED groups, with a significant difference in the former results (oGVHD lower). Nerve fiber density and nerve reflectivity were higher in decreased in oGVHD only. | Cross-sectional study cannot prove causation. Limited patients in the oGVHD group. Treatments not standardized |
Association between Meibomian Gland Atrophy and Corneal Sub-basal Nerve Loss in Chronic Ocular GVHD | O Dikme tas | Patients with chronic GVHD are at high risk for developing DED and MG dysfunction. In chronic GVHD-related DED, MG loss does not appear to be a significant factor for corneal sub-basal nerve damage. | Cross-sectional | 50 | Outpatient | 1 | Confoscan 4, Nidek, Japan |
| Chronic GVHD had worse meibography scores, reduced corneal sub-basal nerve plexus densities, lower TBUT scores, lower Schirmer I values and higher corneal staining scores Corneal sub-basal nerve densities of patients with GVHD did not correlate with meiboscores but showed a weak correlation with Schirmer I test values. | Small sample size No separate group for non-GVHD dry eye patients. |
Face Mask-Related Ocular Surface Modifications During COVID-19 Pandemic | Mastropaqua | The use of FM increases ocular surface inflammation and negatively impacts the quality of life in patients with DED. | Prospective | 128 | Outpatient | 2 (baseline, 90 days) | HRT-RCM | CDCD GCD | DCD significantly increased in prolonged wear, whereas GCD did not significantly change. | No controls not using FMs. Short-term study Long-term studies may reveal FM-related GCD changes. |
Ocular Surface, Meibomian Gland Alterations, and Cornea changes in Chronic Cigarette Smokers. | Ağın | Corneal nerve changes are found in chronic smokers. Smoking has an adverse effect on ocular surface parameters | Cross-sectional case-control | 100 | Outpatient | 1 | Confoscan 3.0 (Nidek) | Basal EC density, anterior and posterior keratocytes, endothelial cell density, long and total sub-basal nerve numbers | Decreased corneal basal epithelium, anterior and posterior keratocytes, endothelial cell density, meibomian gland density, and sub-basal nerve numbers in chronic smokers. | Systemic concentrations of cigarette toxic substances are not assessed in the blood, unclear whether ocular alterations due to systemic effects or direct damage from smoking. |
UV Damage to the Anterior Ocular Surface | Grupcheva | Summer sun exposure leads to changes in the cornea, bulbar and palpebral conjunctiva | Prospective | 400 | Outpatient | 2 (baseline, 1 year) | HRTII-RCM | No and area of cystic changes | Characteristic cystic lesions with dark centers and bright borders in only 25 eyes (6%) before and affecting 118 eyes (29.5%) after summer. The total area of the cysts after the summer increased fivefold. | Same population used as a control—may not have adequate time for washout of effects |
Area of Study | Authors | Main Contribution to Literature | Design | Sample Size | Participants | No of IVCM | HRT | Main Outcomes | Main Findings | Limitations |
---|---|---|---|---|---|---|---|---|---|---|
Corneal Alterations of New Hybrid CL in Advanced Keratoconus | Dikmetas | Hybrid CL: no adverse effects on corneal endothelial cells in advanced keratoconus. | Retrospective study | 32 | Outpatient | 2 (baseline, at 6 months) | IVCM; Confoscan4; Nidek | Corneal endothelial cell density | No significant reduction in epithelial cell density noted at the 6-month compared to baseline after wear | Retrospective design, limited sample size, no control group did not study nerve alterations |
CL Wear on Corneal Epithelial DC Distribution, Density, and Morphology | Golebiowski | Density, distribution, and morphology of CEDC do not differ in established CL wearers | Investigator-masked cross-sectional observational pilot study | 40 | Outpatient | 1 | HRTII-RCM | Corneal epithelial DCs | Relatively lower density of corneal epithelial DCs in the central cornea of younger patients may allude to a more naive immune status in lens wearers | Small sample size |
Microstructural Evaluation of Mucin Balls and Relations to Corneal Surface | Grupcheva | Mucin balls affect the corneal surface, including both epithelial disintegration as well as keratocyte “activation”. | Prospective case-control study | 42 | Outpatient | 2 (baselined at 28 ± 2 days | HRT III-RCM | Appearance and size of the mucin balls Qualitative analysis of shape (round, elliptical, and irregular), reflectivity (bright, homogenous and dark, heterogonous). | Negative correlation between the size of balls and impact on basal epithelium morphology and “activation” of anterior stroma in adjacent areas | Small sample size |
Silicone Hydrogel CL Wear and Corneal Sub-basal Nerve Plexus. | Kocabeyoglu | Sensory adaptation to CL wear is not mediated through sub-basal nerve or reduction of corneal tactile sensitivity in CL-naive users. | Prospective longitudinal study | 40 | Outpatient | 2 (baseline, 6 months) | Confoscan 3.0 (Nidek, Vigonza, Italy) | Corneal sub-basal nerve densities mean total sub-basal nerve fiber length, mean total sub-basal nerve branch density, or the mean long nerve fiber density | No significant changes in outcomes at 6-month follow-up in CL users. | Small sample size |
CL-Related Complications | Li, Weiwei | Complications related to CL wear-most common is dry eye, then SPK | Retrospective | 141 | Outpatient | 1 | Not specified | Visualizing Acanthoemoeba cysts, examining meibomian glands | No cysts found. Meibomian glands described | Mild or asymptomatic complications not observed Only one hospital |
Changes in Tarsal Conjunctiva Associated With Ocular Symptoms and CL Wear | López-de la Rosa | Soft CL wear modifies papillae of epithelial-lamina propria junction into a more rounded shape; however, CL cessation appears to resolve this alteration. | Retrospective | 92 | Outpatient | 1 | HRT III-RCM | Papillae density, shortest diameter, longest diameter, area, circularity, lumen/wall brightness ratio, irregularity, reflectivity, inhomogeneous appearance of the wall, and inhomogeneous appearance of rete ridges | CL wearers, compared to previous wearers and non-wearers, showed higher circularity. Subjects with symptoms, compared to asymptomatic participants, showed higher circularity and lower irregularity | Retrospective nature of study, 2 different questionnaires used for CL wearers and non-CL-wearers, CL material type not controlled |
Changes in Corneal Sub-basal Nerve Morphology and Sensitivity During OK | Lum, Edward | Alterations in corneal nerve morphology occur rapidly with OK and underpin functional sensitivity loss. Nerve fiber orientation provides an index for changes in corneal nerve morphology. | Prospective case-control study | 39 | Outpatient | 3 (baseline, D30, D90) | HRT II RCM | NFD GNFO | In the central cornea, both NFD and corneal sensitivity decreased by Day 30, 90. Reduced NFD is associated with reduced corneal sensitivity. In the mid-peripheral cornea, GNFO rotated clockwise on Day 30, with further rotation on Day 90. Corneal sensitivity reduction plateaued by Day 30. | Difficulties in locating the same exact corneal location with IVCM at multiple visits for each subject, leading to a potential sampling error |
Long-Term Impacts of OK on SNP and Corneal Sensitivity Responses and Their Reversibility | Nombela-Palomo | Long-term OK treatment led to reduced SNP nerve density, directly correlated with corneal tortuosity. After one month of treatment interruption, nerve density was still reduced. | Prospective case-control study | 47 | Outpatient | 3 (baseline, one year, one month after removing lens) | Not specified | SNP | OK wearers: reductions in SNP density and no. of nerves in the central and mid-peripheral cornea Increased central objective tortuosity After lens removal for 1 month, baseline nerve density was not recovered. One year: Increased mid-peripheral Langerhans cell density, Increase in mid-peripheral nerve tortuosity. | Small sample size |
Subclinical Inflammation of the Ocular Surface in Soft CL Wear | Saliman | Daily disposable CL produces minimal subclinical inflammatory response vs. no lens wear over 1 week. | Prospective, longitudinal, observational | 20 | Outpatient | 6: 3 dispensing, 3 follow-up visits | HRT III/RCM |
| All metrics increase in reusable lenses (A2 and AO), while only 3 of 6 IVCM parameters increase in daily disposable group. | Small sample size |
Corneal Health during Three Months of Scleral Lens Wear | Tse V | Scleral lens wear for 3 months does not affect corneal epithelial barrier function, nerve fiber, and DC densities | Prospective, longitudinal, observational | 27 | Outpatient | 3 (baseline, 1, 3 months) | HRT-RCM |
| No differences between CL solutions. No changes after 1 and 3 months of CL use. | No comparison with patients who did not have a scleral lens or other lens types. |
Impact of Lens Care Solutions and Daily Silicone Hydrogel CL Wear on Cornea Epithelium | Zhang XL | IVCM can detect epithelial cellular changes during CL wear | Prospective, investigator masked, cohort study | 274 | Outpatient | 2 (baseline and at 5 months) | ConfoScan4 (Nidek) | Morphologic differences (hyper-reflectivity) in the superficial ECs and epithelial basal cell density | Hyper-reflective superficial ECs associated with PHMB preserved solution; decreased basal EC density associated with bacterial bioburden. | No washout period prior to study entry |
Corneal DC and Sub-basal Nerve in Long-Term CL Wear | Liu Q | IVCM enabled direct observation of increased corneal DC and correlated with loss of SNP. | Prospective, observational | 20 | Outpatient | 4 (1, 4, 12, and 24 weeks) | HRT II-RCM |
| After wearing CLs, corneal DC were activated and increased, indicating ocular surface inflammation and decreased after week 4 | Effect of gender not evaluated Small study |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Sim, R.; Yong, K.; Liu, Y.-C.; Tong, L. In Vivo Confocal Microscopy in Different Types of Dry Eye and Meibomian Gland Dysfunction. J. Clin. Med. 2022, 11, 2349. https://doi.org/10.3390/jcm11092349
Sim R, Yong K, Liu Y-C, Tong L. In Vivo Confocal Microscopy in Different Types of Dry Eye and Meibomian Gland Dysfunction. Journal of Clinical Medicine. 2022; 11(9):2349. https://doi.org/10.3390/jcm11092349
Chicago/Turabian StyleSim, Ralene, Kenneth Yong, Yu-Chi Liu, and Louis Tong. 2022. "In Vivo Confocal Microscopy in Different Types of Dry Eye and Meibomian Gland Dysfunction" Journal of Clinical Medicine 11, no. 9: 2349. https://doi.org/10.3390/jcm11092349
APA StyleSim, R., Yong, K., Liu, Y. -C., & Tong, L. (2022). In Vivo Confocal Microscopy in Different Types of Dry Eye and Meibomian Gland Dysfunction. Journal of Clinical Medicine, 11(9), 2349. https://doi.org/10.3390/jcm11092349